SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001104659-14-009470
Filing Date
2014-02-13
Accepted
2014-02-13 09:05:15
Documents
1
Group Members
SUSQUEHANNA INVESTMENT GROUPSUSQUEHANNA SECURITIES

Document Format Files

Seq Description Document Type Size
1 SC 13G a14-4792_2sc13g.htm SC 13G 115420
  Complete submission text file 0001104659-14-009470.txt   117320
Mailing Address 215 FIRST STREET SUITE 7 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 7 CAMBRIDGE MA 02142 857-242-3700
Sarepta Therapeutics, Inc. (Subject) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: MA | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-54847 | Film No.: 14603266
SIC: 2834 Pharmaceutical Preparations

Mailing Address 401 CITY AVENUE, SUITE 220 BALA CYNWYD PA 19004
Business Address 401 CITY AVENUE, SUITE 220 BALA CYNWYD PA 19004 610-617-2600
SUSQUEHANNA CAPITAL GROUP (Filed by) CIK: 0001446578 (see all company filings)

IRS No.: 232795205
Type: SC 13G